Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
EyePoint Pharmaceuticals Inc. logo

EyePoint Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

10.54
 
USD
  
0.21
  
(2.03%)
Optionable: Yes  Market Cap: 457 M  90-day average vol: 1,209,403

Previous close: 10.33  Open: 10.41  Bid: 9.9  Ask: 10.88
52 week range    
5.67   
   30.99
Last updated: Tuesday 16th July 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

EYPT Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Amortization of intangibles3 M3 M2 M
Basic EPS from continuing operations-3.54-2.03-2.74-1.82
Basic EPS total-3.54-2.03-2.74-1.82
Basic weighted shares outstanding13 M29 M37 M39 M
Cost of sales1 M500000.0
Depreciation189000.0311000.0400000.0500000.0
Depreciation unreconciled2 M
DepreciationAndAmortization189000.0311000.02 M500000.0
Diluted EPS total-3.54-2.03-2.74-1.82
Diluted normalized net income/share-2.03-2.74-1.82
Diluted weighted shares outstanding13 M29 M37 M39 M
GeneralAndAdministrativeExpense21 M26 M35 M40 M
Gross operating profit34 M37 M41 M46 M
ImpairmentOfCapitalAssets21 M
Income before tax-29 M-37 M-102 M-71 M
Income taxes-3 M-3 M-6 M83000.0
InterestExpenseNonOperating7 M5 M3 M1 M
MiscOtherSpecialCharges-847000.02 M572000.06 M
Net income from total operations-45 M-58 M-102 M-71 M
NetIncomeCommonStockholders-29 M-37 M-86 M-62 M
NetIncomeContinuousOperations-45 M-58 M-102 M-71 M
NetNonOperatingInterestIncomeExpense-7 M-5 M-3 M-1 M
Normalized income-40 M
Operating income-37 M-55 M-100 M-75 M
Operating income before depreciation (EBITDA)-18 M-29 M-97 M-69 M
OperatingExpense72 M92 M141 M121 M
Other income net847000.0-2 M-572000.0-6 M
OtherGandA21 M26 M35 M40 M
OtherOperatingExpenses-8 M-11 M-8 M-5 M
Research & development expense17 M29 M50 M65 M
ResearchExpense17 M29 M50 M65 M
Revenue per share3 M3 M2 M
Selling Gen & administrative expense46 M53 M60 M52 M
SellingAndMarketingExpense25 M28 M26 M12 M
Special income/charges-21 M
Total Income available for interest expense (EBIT)-22 M-32 M-99 M-69 M
Total common shares outstanding29 M34 M34 M50 M
Total net income-45 M-58 M-102 M-71 M
Total ordinary shares52 M52 M52 M52 M
Total revenues34 M37 M41 M46 M
TotalExpenses72 M92 M142 M122 M
TotalRevenue34 M37 M41 M46 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University